US Stock MarketDetailed Quotes
PCVX Vaxcyte
- 94.340
- +0.360+0.38%
Close Nov 29 13:00 ET
- 94.340
- 0.0000.00%
Post 17:01 ET
11.76BMarket Cap-20508P/E (TTM)
94.375High91.965Low809.06KVolume93.890Open93.980Pre Close75.85MTurnover0.70%Turnover RatioLossP/E (Static)124.64MShares121.05552wk High3.44P/B10.85BFloat Cap52.74052wk Low--Dividend TTM114.98MShs Float121.055Historical High--Div YieldTTM2.56%Amplitude15.510Historical Low93.755Avg Price1Lot Size
Vaxcyte Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5.49%-60.71M | -93.48%-121.39M | -233.66%-159.12M | -73.97%-296.79M | -97.50%-128.81M | -49.29%-57.55M | -60.36%-62.74M | -72.15%-47.69M | -40.53%-170.6M | -27.65%-65.22M |
| Net income from continuing operations | -11.29%-103.12M | -88.33%-128.7M | -57.16%-95.02M | -80.00%-402.27M | -131.65%-180.8M | -59.99%-92.66M | -40.81%-68.34M | -55.09%-60.46M | -123.31%-223.49M | -173.26%-78.05M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -54.64%44K | --0 |
| Depreciation and amortization | 81.09%4.49M | 44.86%3.48M | 31.98%3.09M | 10.60%10.17M | 28.17%2.95M | 5.35%2.48M | 10.49%2.4M | -1.14%2.34M | 166.01%9.2M | 90.71%2.3M |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8M | ---- |
| Change In working capital | -14.04%29.22M | -412.22%-7.79M | -1,190.27%-73.83M | 538.45%81.32M | 1,253.45%38.06M | 220.49%33.99M | 140.46%2.5M | 54.12%6.77M | 134.42%12.74M | 87.98%-3.3M |
| -Change in prepaid assets | -107.94%-566K | 33,166.67%2.99M | -5.44%-4.96M | 4,027.02%17.87M | 738.24%15.44M | 289.29%7.12M | 100.51%9K | -268.47%-4.7M | 105.88%433K | -127.07%-2.42M |
| -Change in payables and accrued expense | 69.92%37.78M | -352.93%-10.37M | -538.71%-50.52M | 562.36%92.02M | 1,613.76%54.17M | 136.52%22.23M | 158.51%4.1M | 4,633.86%11.52M | 184.66%13.89M | 112.91%3.16M |
| -Change in other current assets | -4,138.11%-11.55M | -1,516.88%-6.55M | -1,495.28%-8.58M | -10,594.84%-49.73M | -74,149.28%-51.09M | -64.34%286K | 91.70%462K | 139.00%615K | 86.86%-465K | 113.56%69K |
| -Change in other current liabilities | 269.86%2.38M | -33.65%-1.84M | -33.04%-1.8M | 880.36%11.28M | 937.83%15.42M | 1.62%-1.4M | -14.19%-1.38M | -124.13%-1.36M | 108.95%1.15M | 85.60%-1.84M |
| -Change in other working capital | ---- | ---- | -1,239.91%-7.97M | 534.11%9.88M | 281.90%4.13M | ---- | ---- | 131.99%699K | -171.77%-2.28M | -264.68%-2.27M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -5.49%-60.71M | -93.48%-121.39M | -233.66%-159.12M | -73.97%-296.79M | -97.50%-128.81M | -49.29%-57.55M | -60.36%-62.74M | -72.15%-47.69M | -40.53%-170.6M | -27.65%-65.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -4,215.88%-917.02M | 75.89%-80.41M | -0.66%-451.07M | -1,136.82%-773.31M | 61.27%-13.93M | -35.80%22.28M | -1,374.85%-333.56M | -1,002.23%-448.1M | 135.13%74.59M | -43,943.90%-35.95M |
| Net PPE purchase and sale | -418.87%-38.08M | -1,921.50%-38.98M | -115.23%-12.07M | -1,062.08%-67.88M | -4,875.50%-57.07M | -770.58%-7.34M | 328.14%2.14M | -92.55%-5.61M | 10.54%-5.84M | 15.41%-1.15M |
| Net investment purchase and sale | -3,067.48%-878.94M | 87.66%-41.43M | 0.79%-439M | -977.12%-705.43M | 223.96%43.14M | -16.68%29.62M | -1,338.62%-335.7M | -941.58%-442.49M | 139.08%80.43M | -2,520.38%-34.81M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -4,215.88%-917.02M | 75.89%-80.41M | -0.66%-451.07M | -1,136.82%-773.31M | 61.27%-13.93M | -35.80%22.28M | -1,374.85%-333.56M | -1,002.23%-448.1M | 135.13%74.59M | -43,943.90%-35.95M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,020.57%1.52B | -79.82%110.37M | 1,868.62%818.2M | -25.74%639.81M | -99.58%2.74M | 10.30%48.55M | 996.61%546.97M | -62.56%41.56M | 4,741.24%861.55M | 7,400.95%656.63M |
| Net common stock issuance | 2,987.01%1.51B | -80.46%106.53M | 1,853.90%816.48M | -25.74%636.04M | -100.00%-23K | 13.63%49M | 1,012.72%545.28M | -62.26%41.79M | 6,063.50%856.48M | 9,529.02%653.62M |
| Proceeds from stock option exercised by employees | 444.64%11.74M | 131.40%4.4M | 900.80%5.02M | 28.98%7.65M | 2.42%3.09M | 22.65%2.16M | 117.51%1.9M | 78.01%502K | 52.00%5.93M | 53.36%3.02M |
| Net other financing activities | -258.39%-9.34M | -164.02%-565K | -354.75%-3.31M | -350.17%-3.88M | ---330K | ---2.61M | ---214K | ---727K | ---861K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,020.57%1.52B | -79.82%110.37M | 1,868.62%818.2M | -25.74%639.81M | -99.58%2.74M | 10.30%48.55M | 996.61%546.97M | -62.56%41.56M | 4,741.24%861.55M | 7,400.95%656.63M |
| Net cash flow | ||||||||||
| Beginning cash position | -2.28%519.77M | 60.66%612.62M | -52.30%398.55M | 1,096.07%835.53M | 95.59%546.24M | 122.51%531.9M | 88.20%381.32M | 1,096.07%835.53M | -81.91%69.86M | 147.33%279.27M |
| Current changes in cash | 3,945.40%537.31M | -160.69%-91.43M | 145.79%208M | -156.21%-430.29M | -125.20%-140M | -66.94%13.28M | 308.10%150.66M | -441.57%-454.23M | 342.33%765.54M | 1,414.48%555.46M |
| Effect of exchange rate changes | -630.54%-5.58M | -1,707.69%-1.41M | 26,256.52%6.06M | -4,980.29%-6.69M | -1,065.08%-7.68M | 1,883.02%1.05M | 83.92%-78K | 110.13%23K | 131.21%137K | 199.25%796K |
| End cash Position | 92.50%1.05B | -2.28%519.77M | 60.66%612.62M | -52.30%398.55M | -52.30%398.55M | 95.59%546.24M | 122.51%531.9M | 88.20%381.32M | 1,096.07%835.53M | 1,096.07%835.53M |
| Free cash flow | -52.25%-98.79M | -164.63%-160.37M | -221.20%-171.2M | -106.67%-364.67M | -180.07%-185.88M | -64.73%-64.89M | -51.26%-60.6M | -74.05%-53.3M | -37.90%-176.45M | -26.48%-66.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data